ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 85 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | 0.0% | 1,200 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 1,200 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -50.0% | 1,200 | -49.2% | 0.00% | – |
| Q2 2018 | $6,000 | +50.0% | 2,364 | +97.0% | 0.00% | – |
| Q1 2018 | $4,000 | -85.2% | 1,200 | -81.4% | 0.00% | – |
| Q4 2017 | $27,000 | +8.0% | 6,437 | +19.0% | 0.00% | – |
| Q3 2017 | $25,000 | +108.3% | 5,411 | +47.6% | 0.00% | – |
| Q2 2017 | $12,000 | -67.6% | 3,666 | -8.1% | 0.00% | – |
| Q1 2017 | $37,000 | -43.1% | 3,987 | -52.0% | 0.00% | – |
| Q4 2016 | $65,000 | -35.0% | 8,313 | -5.2% | 0.00% | – |
| Q3 2016 | $100,000 | +88.7% | 8,770 | +104.7% | 0.00% | – |
| Q2 2016 | $53,000 | -17.2% | 4,284 | -32.5% | 0.00% | – |
| Q1 2016 | $64,000 | -77.1% | 6,343 | -48.8% | 0.00% | – |
| Q4 2015 | $279,000 | +310.3% | 12,381 | +201.3% | 0.00% | – |
| Q3 2015 | $68,000 | -44.3% | 4,109 | -24.1% | 0.00% | – |
| Q2 2015 | $122,000 | +7.0% | 5,417 | +22.9% | 0.00% | – |
| Q1 2015 | $114,000 | +52.0% | 4,409 | +28.8% | 0.00% | – |
| Q4 2014 | $75,000 | – | 3,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|